市场调查报告书
商品编码
1500499
动物疫苗市场:按动物类型、技术、给药途径、分销管道划分 - 全球预测 2024-2030Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年动物疫苗市场规模为98.2亿美元,预计2024年将达104亿美元,2030年将达151.9亿美元,复合年增长率为6.43%。
兽用疫苗是生物製备的物质,可以刺激动物的免疫系统并保护其免受某些疾病的侵害。这些疫苗的功能与人类疫苗类似,是将抗原(通常是灭活或减毒的病原体或其成分)引入动物体内。这种暴露会引发免疫反应,包括产生抗体、记忆细胞和其他防御机制,使动物能够对目标疾病产生免疫力而不会生病。宠物数量的增加、牲畜数量的增加、通用感染疾病意识的增强、动物疾病的快速增加以及动物健康投资的增加正在推动进一步的增长。但由于疫苗储存成本高、运输过程中难以维持疫苗活力,扩大市场有重大问题。由于宠物主人数量的增加和生物技术研究的进步,人们对食品安全的兴趣日益浓厚,正在市场上创造巨大的商机。
主要市场统计 | |
---|---|
基准年[2023] | 98.2亿美元 |
预测年份 [2024] | 104亿美元 |
预测年份 [2030] | 151.9亿美元 |
复合年增长率(%) | 6.43% |
区域洞察
美洲的兽用疫苗采用率最高,主要是因为动物数量众多以及动物健康意识的增加。当地动物卫生机构制定的各种法规和指南极大地推动了疫苗的采用。在欧洲、中东和非洲地区,欧洲在兽用疫苗的采用方面处于领先地位,该地区先进的医疗和技术基础设施、强有力的法律规范以及促进动物福利的倡议对这一增长做出了重大贡献。随着旨在改善兽医卫生系统的投资和努力的增加,中东和非洲正在显示出成长潜力。亚太地区畜牧业人口较多,宠物拥有率较高,兽用疫苗普及潜力大。快速的都市化和宠物拥有的增加,以及政府关于疾病预防的指令,正在推动市场扩张。在亚太地区国家,由于伴同性动物的饲养和认识的提高,都市区的疫苗接种普及不断提高,人们对动物健康的兴趣日益浓厚。
FPNV定位矩阵
FPNV 定位矩阵对于评估兽用疫苗市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对兽用疫苗市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在动物疫苗市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[196 Pages Report] The Veterinary Vaccines Market size was estimated at USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030.
Veterinary vaccines are biologically prepared substances that stimulate an animal's immune system to protect it from specific diseases. These vaccines function similarly to human vaccines by introducing antigens, typically inactivated or attenuated forms of pathogens or their components, into the animal's body. This exposure triggers an immune response, including producing antibodies, memory cells, and other defense mechanisms, so the animal can develop immunity to the targeted disease without getting sick. Increasing pet adoption, livestock population, rising awareness of zoonotic diseases, surging incidences of animal diseases, and escalating investments in animal health drive further growth. However, the high cost of vaccine storage and difficulties in maintaining the viability of vaccines during transport pose significant issues in the market expansion. The increasing count of in-house pets escalated the focus on food safety, and advancements in biotechnological research provide significant opportunities in the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 9.82 billion |
Estimated Year [2024] | USD 10.40 billion |
Forecast Year [2030] | USD 15.19 billion |
CAGR (%) | 6.43% |
Regional Insights
The Americas exhibits the highest adoption of veterinary vaccines, primarily due to the high animal population and increasing awareness of animal health. Various regulations and guidelines set by local animal health organizations have substantially driven vaccine adoption. In EMEA, Europe leads in adopting veterinary vaccines owing to the region's advanced medical and technological infrastructure, robust regulatory frameworks, and initiatives promoting animal welfare, significantly contributing to this growth. In the Middle East and Africa, increasing investments and efforts towards improving animal health care systems signify growth potential. APAC, home to a large livestock population and high pet ownership, presents significant potential for veterinary vaccine adoption. Rapid urbanization and increasing pet adoption rates facilitate market expansion alongside governmental directives on disease prevention. The APAC Countries have been increasingly focusing on animal health as urban areas report high vaccine adoption due to increasing companion animal ownership and awareness.
Market Insights
The market dynamics represent an ever-changing landscape of the Veterinary Vaccines Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Vaccines Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Vaccines Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Merck Animal Health launches 3-in-one swine vaccine
Merck introduced an innovative three-in-one vaccine, Circumvent CML, for Veterinary Vaccines. This groundbreaking vaccine effectively controls Porcine Circovirus Type 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis diseases. It offers the added convenience of reduced volume in a single-dose administration, making it easier for producers to administer. [Published On: 2023-06-14]
IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
Indian Immunologicals Ltd (IIL) is making a substantial investment of INR 700 crore to establish a state-of-the-art veterinary vaccine manufacturing facility in Hyderabad's Genome Valley. This greenfield facility focuses on producing vaccines for animal conditions such as foot and mouth disease and other emerging diseases. Once operational, the manufacturing plant will significantly increase IIL's FMD vaccine capacity from 300 million doses per annum to an impressive 600 million doses per annum. [Published On: 2022-10-11]
Merck Animal Health to Acquire Venc
Merck Animal Health has recently announced the signing of a definitive agreement to acquire Vence, developed virtual fencing for livestock management and rotational grazing in the context of veterinary vaccines. Vence's virtual fencing technology offers numerous benefits, including reducing the need for physical fencing and labor. It enables producers and ranchers to efficiently manage cattle movement and facilitate rotational grazing, all from the convenience of a computer or smartphone. [Published On: 2022-09-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Vaccines Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..
Market Segmentation & Coverage